NeoGenomics (United States)

NeoGenomics (United States)

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is a high-complexity CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for NeoGenomics (United States), United States, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

51%


Total
Publications

400


Total Open
Publications

203


Total
Citations

5.9K


Open Access
Percentage

51%


Total
Publications

400


Total Open
Publications

203


Total
Citations

5.9K

Wikipedia

Website

download

Breakdown

23% 20% 8% 49%

Publisher Open

23%

Both

20%

Other Platform Open

8%

Closed

49%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

010203040506070Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

26%OA Journal

OA Journal 26%

46

Hybrid 28%

48

No Guarantees 46%

79

Other Platform Open

Domain 79%

88

Institution 26%

29

Preprint 21%

23

Other Internet 16%

18

Public 8%

9

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
89
Europe PMC
Domain
43
Figshare
Public
13
Research Square
Preprint
9
DOI
Other Internet
9
bioRxiv
Preprint
8
Semantic Scholar
Public
7
University of Southern Denmark - University of Southern Denmark Research Portal
Institution
6
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes
Institution
5
Aalborg Universitet - VBN Forskningsportal
Other Internet
5
1 / 5

Data updated 8 December 2024

Share

Share

Share